Louisiana 2017 Regular Session

Louisiana Senate Bill SB59

Introduced
3/28/17  
Introduced
3/28/17  
Refer
3/28/17  
Refer
3/28/17  
Refer
4/10/17  
Refer
4/10/17  
Report Pass
5/3/17  
Engrossed
5/11/17  
Refer
5/15/17  
Refer
5/15/17  
Report Pass
5/23/17  
Report Pass
5/23/17  
Enrolled
6/3/17  
Chaptered
6/14/17  

Caption

Provides relative to prescription drug price information. (gov sig)

Companion Bills

No companion bills found.

Previously Filed As

LA HB277

Requires educational or marketing materials for prescription drugs directed to healthcare providers to include price information (OR SEE FISC NOTE GF EX)

LA SB401

Provides for a Prescription Drug Affordability Board. (8/1/26)

LA SB368

Provides for prescription drug pricing. (8/1/26) (OR +$270,360 SG EX See Note)

LA SB289

Relating to prescription drugs.

LA SB369

Provides for prescription drug pricing. (1/1/27) (EG SG EX See Note)

LA S875

To promote transparency in prescription drug prices

LA SB243

Provides relative to the sales and use tax exemption for the sale of certain prescription drugs. (gov sig) (EN SEE FISC NOTE LF RV See Note)

LA A02126

Establishes a pilot program on the referenced rate for prescription drugs; relates to reducing the cost of prescription drugs by establishing maximum wholesale drug prices that are the same as the prices in Canada.

LA S01351

Establishes a pilot program on the referenced rate for prescription drugs; relates to reducing the cost of prescription drugs by establishing maximum wholesale drug prices that are the same as the prices in Canada.

LA SB1509

Relating To Prescription Drugs.

Similar Bills

LA HB918

Provides relative to pharmaceutical costs (OR +$153,127 GF EX See Note)

LA SB401

Provides for a Prescription Drug Affordability Board. (8/1/26)

LA SB2

Extends prescriptive period for certain delictual actions from one to two years. (1/1/21) (OR SEE FISC NOTE GF EX)

LA SB243

Provides relative to the sales and use tax exemption for the sale of certain prescription drugs. (gov sig) (EN SEE FISC NOTE LF RV See Note)

LA HB1093

Creates the Louisiana Board of Naturopathic Medicine

LA HB264

Provides for transparency and compensation practices relative to pharmacy benefit managers (EN +$90,000 SG EX See Note)

LA HB5

Provides for the emergency suspension of time limitations in certain civil proceedings (Item #40)

LA HCR50

Requests certain state and governmental entities to report on opioid abatement and treatment programs in correctional facilities, and to clarify guidance regarding available funding for such programs